AntiCoagulant Effectiveness in Idiopathic Pulmonary Fibrosis (ACE-IPF)
收藏DataCite Commons2026-02-05 更新2026-05-07 收录
下载链接：
https://search.vivli.org/doiLanding/studies/00000091/isLanding
下载链接
链接失效反馈官方服务：
资源简介：
This study will test the effectiveness of warfarin in patients with IPF. Approximately 256 patients will be randomized 1:1 to either warfarin or placebo. Patients will return at week 1 for a safety review and every 16 weeks for 48 weeks. The primary endpoint in the study is the time to either death, non-bleeding/non-elective hospitalization, or a drop of greater than 10% in forced vital capacity (FVC) from baseline.
提供机构：
Vivli
创建时间：
2018-10-27
